AGM/EGMJun 24, 2026, 05:03 PM
Lucid Diagnostics Increases Authorized Shares to 400M
AI Summary
Lucid Diagnostics Inc. held its Annual Meeting of Stockholders on June 24, 2026, with approximately 84.7% of shares represented. Stockholders re-elected all management-nominated directors and approved an amendment to increase the total authorized common stock by 100,000,000 shares, raising the total to 400,000,000 shares. Additionally, the appointment of CBIZ CPAs P.C. as the independent registered certified public accounting firm for 2025 was ratified.
Key Highlights
- Stockholders representing 84.7% of outstanding shares attended the Annual Meeting.
- Shareholders re-elected James L. Cox, John R. Palumbo, and Ronald M. Sparks as Class B directors.
- The company increased authorized common stock by 100,000,000 shares, from 300,000,000 to 400,000,000.
- The amendment to increase authorized shares was approved with 152,941,468 votes For.
- Stockholders ratified CBIZ CPAs P.C. as the independent auditor for 2025 with 161,813,118 votes For.
Price Impact
More from LUCD